From Name:
From Email:
To Name:
To Email:

Optional Message:

FDA approves Otezla, a new pill for psoriatic arthritis

from Healthline

In giving a nod to Celgene's Otezla, the U.S. Food and Drug Administration is offering active psoriatic arthritis patients a new treatment option that is taken orally, in pill form. Injected corticosteroids, tumor necrosis factor blockers, and interleukin-12/interleukin-23 inhibitors are among the treatments currently available. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063